Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EP Minerals is an industrial minerals and engineered materials business focused on diatomaceous earth, perlite, clay and related specialty mineral products. The company supplies filter aids, absorbents, catalysts, carriers and functional additives used across food and beverage processing, biofuels, agriculture, water purification, oil and gas, paint, plastics and other industrial markets. It is not a biotech, pharma or healthcare company, although some of its materials are used in applications such as pharmaceuticals and water purification. EP Minerals was acquired by U.S. Silica in 2018 and continues to operate as a branded business within U.S. Silica's industrial and specialty products portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EP Minerals.